INTERNACIONAL
Lawsuit alleges anti-Israel group leaders are ‘Hamas’ foot soldiers in New York City’

A lawsuit filed in the Southern District of New York last month claims the leaders of several radical anti-Israel groups involved in 18 months of disruptive, violent and antisemitic protests on campuses and in the streets of New York City are «accountable for aiding and abetting Hamas’ continuing acts of international terrorism.»
In purported violation of the Antiterrorism Act and the Alien Tort Statue, the defendants are said to have «acted as Hamas’ foot soldiers in New York City,» and may have had foreknowledge of the designated foreign terror organization’s devastating Oct. 7 attacks.
Defendants in the case are Within Our Lifetime and its founder Nerdeen Kiswani, Columbia Students for Justice in Palestine (SJP) and its representative Maryam Alwan, Columbia-Barnard Jewish Voice for Peace (JVP) and its representative Cameron Jones, and Columbia University Apartheid Divest (CUAD) and its representative Mahmoud Khalil, who is currently in custody of Immigration and Customs Enforcement (ICE).
The lawsuit asserts that the associational defendants have «distribute[d] Hamas-created and affiliated propaganda, incite[d] fear and violence, and attack[ed] critical academic, economic, and infrastructure centers in New York City,» as well as having «repeatedly terrorized and assaulted Jews across New York City and on Columbia University’s campus, physically assaulted Columbia University employees, and illegally seized and damaged public and private property.»
DUFFY SLAMS MTA OVER ‘FACT CHECK’ ON ANTI-ISRAEL MOB’S GRAND CENTRAL TAKEOVER
Nerdeen Kiswani, co-founder and leader of Within Our Lifetime, speaks at a demonstration near Columbia University on Feb. 2, 2024, in New York City. (Alexi J. Rosenfeld/Getty Images)
The details of the allegations are thorough. To demonstrate how the defendants «resoundingly and knowingly answered Hamas’ call to action» on and after Oct. 7, the lawsuit cites how the defendants knowingly «obtain[ed] and disseminat[ed]» a Hamas propaganda document, which contained directions created by the Hamas Media Office for spinning the narrative of their deadly attacks. By «painstakingly follow[ing]» the document, the lawsuit alleges defendants «directly responded to, and followed orders from, Hamas.»
The lawsuit also supplies several indicators that defendants may have had foreknowledge of the heinous Oct. 7 attack, to include «a highly suggestive social media post published moments before the October 7 attack began» in which Columbia SJP posted on Instagram «We are back!!» after a months-long hiatus.
On Oct. 7, Kiswani utilized marketing materials that «would not be released until the next day» in a National Students for Justice in Palestine (NSJP) «Toolkit» demonstrating how SJP organizations across the country could support the Gazan «resistance.»

Emaciated Israeli hostages, from left, Ohad Ben Ami, Eli Sharabi and Or Levy are taken by terrorists to a stage before being handed over to the Red Cross in Deir al-Balah in the central Gaza Strip on Feb. 8, 2025. (AP/Abdel Kareem Hana)
Following Oct. 7, Within Our Lifetime promoted a «Day of Rage» in New York City while Columbia SJP and Columbia JVP promoted their own «Day of Resistance.» The mere announcements of these events forced closures of Jewish schools and institutions, and «even forced Columbia University – a non-Jewish institution – to close its campus as a safety precaution,» while Jewish students «were advised to lock their doors and remain inside for their own safety,» according to the lawsuit.
The lawsuit names Khalil as the purported leader of Columbia SJP’s Day of Resistance.
COLUMBIA’S ANTI-ISRAEL PROTESTERS SAY TRUMP PULLING $400 MILLION IN GRANTS FROM UNIVERSITY IS A ‘SCARE TACTIC’
In November 2023, the suit describes how a «’Shut it Down for Palestine’ event descended into – as planned – anti-Jewish and vitriolic hatred and threats,» with speakers shouting «Death to Jews!» and «encourage[ing] Hamas and… comrades across Columbia’s campus to hunt down and assault pro-Israel students.»
The next day, Columbia University suspended Columbia SJP and Columbia JVP, at which time «Khalil and former members and/or organizers of Columbia SJP became leaders of CUAD.» As a result, CUAD «became the primary organizer of the violent and antisemitic protests that would foment terror, sow discord, and disrupt campus life at Columbia for over a year.»

Hamas terrorists kidnap a bloodied Israeli woman into the Gaza Strip. (Hamas-Telegram)
Khalil would later become the lead negotiator of the Columbia encampment, which the lawsuit notes was «well-supplied with identical tents, toiletries, food, and professional signage.» Based on a statement from Shlomi Ziv, a plaintiff in the lawsuit who was held captive by Hamas for 246 days following his kidnapping at the Nova Music Festival, «Hamas and [American Muslims for Palestine (AMP)]/NSJP provided financial, organizational, and other support… for the Encampment.»
Ziv alleges that his «Hamas captors bragged about having Hamas operatives on American university campuses,» and even «showed him Al-Jazeera stories and photographs of protests at Columbia University that were organized by Associational Defendants.»
APPARENT ANTI-ISRAEL ACTIVISTS SPLASH RED PAINT ON HOMES OF JEWISH OFFICIALS AT BROOKLYN MUSEUM

Anti-Israel demonstrators attend a protest at Columbia University in New York City, just days after the Hamas slaughter in southern Israel, Oct. 12, 2023. (Julia Bonavita/Fox News Digital)
Given the «legal chasm between independent political advocacy and coordinating with a foreign terrorist organization to seed pro-terror propaganda throughout America’s largest city,» the lawsuit alleges the defendants’ «actions violate the Antiterrorism Act and the law of nations.»
According to the Jerusalem Post, the National Jewish Advocacy Center, Greenberg Traurig LLP, the Schoen Law Firm, and the Holtzman Vogel Law Firm filed the suit on behalf of plaintiffs who include Ziv, several Columbia University students who have served with the Israel Defense Forces, and a number of American and Israeli citizens whose family members, most of whom are believed dead, remain in Hamas captivity.

People protest the banning of Students for Justice in Palestine and Jewish Voice for Peace at Columbia University on Nov. 20, 2023 in New York City. (Michael M. Santiago/Getty Images)
The lawsuit especially states that Khalil, «on information and belief, directly coordinates with Hamas, AMP/NSJP and/or other agents and affiliates of Hamas and related terrorist organizations.» The filers state that his detention by ICE in March may have been «based on many of his actions described in this Complaint.»
Khalil’s involvement in the Columbia protests was cited as a rationale for his removal during his April 11 hearing, when Judge Jamee Comans ruled that Khalil may be deported. Khalil also withheld past employment with the Syrian office in the Beirut British Embassy and the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) as well as his membership in the CUAD when applying for a green card.
This withholding of information, according to federal officials, made Khalil «inadmissible at the time of his adjustment.»
CLICK HERE TO GET THE FOX NEWS APP
Disruptive events in New York City show no signs of abating. In March, students stormed a classroom at Columbia University and took over a building in affiliated Barnard College, where they assaulted an employee. A Within Our Lifetime protest on April 7 «took over» the main concourse of Grand Central Station.
Fox News Digital reached out to CUAD, Columbia SJP, Within Our Lifetime, and Columbia-Barnard JVP for comment about the allegations contained within the lawsuit, but received no response.
INTERNACIONAL
Los aldeanos dicen que esta isla está maldita. Los inmigrantes vieron una oportunidad

INTERNACIONAL
Bipartisan Senate bill to cap insulin for Americans at $35 has new momentum

NEWYou can now listen to Fox News articles!
A bipartisan group of senators is resurfacing legislation to cap many American patients’ insulin costs at $35 a month — the INSULIN Act of 2026 — reviving a push that previously stalled.
The bill co-authored by Sens. Jeanne Shaheen, D-N.H., Susan Collins, R-Maine, Raphael Warnock, D-Ga., and John Kennedy, R-La., would bar group and individual health plans from imposing deductibles on selected insulin products and could not charge more than $35 for a 30-day supply starting in plan year 2027.
Beginning in 2028, patients would pay the lesser of $35 or 25% of the negotiated net price.
Congress had already mandated a Medicare-only cap of $35 in 2022, and President Donald Trump’s long-running agenda to lower prescription medicine costs gives the effort some momentum before the 2026 midterms, where Collins’ seat could be targeted for a Democrat flip amid the very narrow Republican Senate majority (53-47).
SENATE QUIETLY WORKS ON BIPARTISAN OBAMACARE FIX AS HEALTHCARE CLIFF NEARS
Sen. Susan Collins, R-Maine, is helping to lead the effort to cap insulin costs on Americans at $35 per month. (Tom Williams/CQ-Roll Call, Inc via Getty Images)
«We are the long-time chairs of the Senate Diabetes Caucus, and one of our top priorities is to make insulin more affordable,» Collins said in a Senate hearing last week.
«Our INSULIN Act would impose out-of-pocket limits for patients with commercial insurance, tackle commercial pharmacy benefit managers, and ensure that patients are the ones who are benefiting from the savings that they negotiate, and encourage biosimilar competition in order to lower list prices.»
The bill, first introduced in 2023, has been reworked at Kennedy and Warnock’s urging to include some work to provide capped insulin prices even for the uninsured.
«Our bill also includes provisions to help uninsured Americans access affordable insulin,» Collins continued. «Just this week, I met with a young woman who, a few years ago, ended up in the hospital because she was stretching out her insulin, not taking as much as she was prescribed, because she simply couldn’t afford the cost.»
REPORTER’S NOTEBOOK: GOP TARGETS AFFORDABILITY WITH RECONCILIATION 2.0 PLAN AHEAD OF MIDTERMS
The issue aligns with a 2024 Trump presidential campaign vow. Trump has already announced other initiatives to lower prescription drug prices, including an executive order last May on his «Most Favored Nation» (MNF) policy to take action on Big Pharma companies that are not offering the world’s lowest price on drugs to Americans.
«Americans should not be forced to subsidize low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States,» Trump’s policy ordered. «Americans must therefore have access to the most-favored-nation price for these products.»
«My Administration will take immediate steps to end global freeloading and, should drug manufacturers fail to offer American consumers the most-favored-nation’s lowest price, my Administration will take additional aggressive action.»
Then, this December, Trump announced agreements with nine Big Pharma companies to lower prices on Americans under the MFN policy, including offering direct to the consumer lowest pricing on TrumpRx, the president’s new prescription drug portal.
GOP MUST RACE FOR NEW ‘BIG, BEAUTIFUL BILL’ TO SLASH COSTS BEFORE MIDTERMS, TOP HOUSE REPUBLICANS WARN
TrumpRX lists Insulin Lispro from Eli Lilly for $25.

Sen. Janine Shaheen, D-N.H., announced last March that she would not be running for reelection. (Nathan Posner/Anadolu via Getty Images)
Collin and Shaheen’s legislation would also offer a limited cap on insulin for the uninsured — an issue reportedly driven by Warnock and Kennedy in the bipartisan group — creating a five-year pilot in 10 states to help uninsured patients get insulin for no more than $35 a month.
«We have already capped insulin for Medicare enrollees at $35 a month — this new INSULIN Act, which we plan to introduce next [this] week, will address insulin affordability for children, adults and those who are uninsured,» Shaheen said in a statement.
«It will do, as the Medicare provision does, cap the cost of employer and private insurance coverage of insulin at $35 a month, create a pilot program to provide $35 a month insulin for uninsured diabetes patients, and it is a direct way to help American families facing economic pressures, and will make people healthier in the long run.»
TRUMP’S RX PLAN PROMISES SAVINGS, BUT ECONOMISTS SEE A HIDDEN TRADE-OFF
While Collins might need the bill for her 2026 midterm election hopes. Shaheen is serving out her final year in the Senate.
«I would really like to be able to leave the Senate thinking that we had helped to address insulin costs for a lot of Americans: This is the most expensive chronic disease,» Shaheen told Semafor, noting Trump’s agenda for capping prices.
«This is something that he should support, because it is affordability.»
Affordability has been the Democrats’ buzzword for the midterms, but Republicans and Trump have argued it has only been an issue Democrats have made after years of inflation under former President Joe Biden.
TRUMP ENDS BIDEN’S DRUG PRICE NIGHTMARE — AMERICANS GET REAL RELIEF WITH TRUMPRX

Sen. John Kennedy, R-La., was a part of the bipartisan Senate group pushing the INSULIN Act of 2026 to include provisions to lower insulin costs for the uninsured, too. (Anna Moneymaker / POOL / AFP)
The bill authorizes $100 million for fiscal 2027 for cost-cutting and defines «affordable» insulin as out-of-pocket costs of no more than $35 for a one-month supply.
Collins framed the measure as a response to patients rationing medicine they need to survive.
«I have heard far too many stories from people in Maine and across the country who have been forced to ration their insulin because of the cost, and that is simply unacceptable,» she told Semafor.
Beyond the consumer cap, the bill also tries to lower underlying costs by targeting pharmacy benefit manager practices and encouraging more competition from biosimilars and generics. It orders a federal study on delays in bringing insulin products to market and barriers to biosimilar uptake.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The proposal now faces the harder political test: winning buy-in from Senate leadership and finding a path to must-pass legislation later this year. But after years of failed starts, backers say they finally have a bipartisan framework that could move.
senate, health care healthy living, health care, health care senate, midterm elections
INTERNACIONAL
El gobierno de Chile le retiró el apoyo a Bachelet para la ONU: por qué beneficia al argentino Rafael Grossi

En la frenética carrera para acceder al máximo cargo de las Naciones Unidas (ONU), el diplomático argentino Rafael Grossi parece haber recibido una buena noticia para sus pretensiones con la decisión de Chile de retirar el apoyo a la expresidenta trasandina Michelle Bachelet.
“Hemos llegado a la convicción que el contexto de esta elección, la dispersión de candidaturas de países de América Latina y las diferencias con algunos de los actores relevantes que definen este proceso, hacen inviable esta candidatura y el eventual éxito de esta postulación”, esgrimió en un escueto comunicado el actual gobierno de José Antonio Kast.
La candidatura de Bachelet seguirá adelante porque al momento de su lanzamiento contaba también con el apoyo de Brasil y México. Fue una astuta jugada del por entonces presidente Gabriel Boric a sabiendas de que existía la posibilidad de que el nuevo mandatario Kast hiciera lo que terminó haciendo: retirarle el apoyo.
Pese a las reiteradas críticas de Javier Milei al sistema multilateral en general y a la ONU en particular, el gobierno argentino se comprometió en apoyar y trabajar para impulsar la candidatura de Grossi, renombrado diplomático que en la actualidad encabeza el trascendental Organismo Internacional de Energía Atómica (OEIA). La Cancillería argentina designó a un equipo especial para acompañar la candidatura de Rafael Grossi. (Foto: REUTERS/Tomas Cuesta)
Durante el lanzamiento formal de su candidatura en la Argentina en diciembre del año pasado, TN pudo confirmar que la Cancillería a cargo de Pablo Quirno designó a un grupo de diplomáticos que desde Buenos Aires monitorearía el proceso junto con la representación permanente de nuestro país en la sede de la ONU en Nueva York.
La retirada del apoyo por parte de Chile podría leerse como un contundente mensaje de que Bachelet no puede lograr un consenso interno ni siquiera en esta importante postulación, lo que podría debilitar su carrera. De todos modos, Brasil es un país de peso que busca tener una banca en una hipotética –y compleja- reforma del Consejo de Seguridad.
Leé también: Rafael Grossi busca convertirse en el primer argentino en liderar la ONU: lanza su candidatura en Buenos Aires
Además de Grossi y Bachelet, los otros candidatos que están en carrera para convertirse en secretario general de la ONU son: la argentina Virginia Gamba, impulsada por Maldivas; Rebeca Grynspan Mayufis, apoyada por su país Costa Rica; y el senegalés Macky Sall, que cuenta con el respaldo de Burundi.
Existe una regla no escrita que el próximo secretario general debe ser latinoamericano. Sólo hubo uno en la historia. El peruano Javier Pérez de Cuéllar ocupó ese cargo durante dos períodos entre 1982 y 1991.
La costarricense Grynspan Mayufis es una de las que, a priori, podría competir cabeza a cabeza con Grossi si la candidatura de Bachelet termina perdiendo peso.

La costarricense Rebeca Grynspan es otra de las favoritas para el máximo cargo de la ONU. (Foto: REUTERS/Mayela Lopez)
La clave está en la decisión de los cinco miembros permanentes del Consejo de Seguridad (Estados Unidos, Rusia, China, Francia y el Reino Unido), quienes tienen que seleccionar a uno de los candidatos para postularlo frente a la Asamblea General. Será una única opción la que salga desde el máximo órgano de la ONU.
Por ello, es necesario esquivar un veto de estos países. Con que uno sólo decida vetar un nombre, esa persona no podrá continuar en carrera. El perfil dialoguista pero firme de Grossi gusta en el ámbito de la diplomacia internacional. A lo largo de los últimos años pudo demostrar su capacidad de negociar con Putin en el Kremlin, con Zelenski en Kiev o con representantes iraníes el desarrollo de su programa nuclear.
Con las audiencias y exposiciones públicas que los candidatos tendrán en los próximos meses se empezará a dilucidar con mayor claridad las posibilidades reales de cada uno. Puertas adentro de la Casa Rosada, la quita del apoyo de Kast a Bachelet fue leída como una buena noticia para Grossi.
naciones unidas, ONU, Rafael Grossi, Michelle Bachelet
POLITICA2 días agoEl mensaje de Milei sobre la “traición” que llamó la atención en el Gobierno y también en la oposición
POLITICA21 horas ago24 DE MARZO: La historia completa que el relato omitió sobre el golpe de 1976 y el Juicio a las Juntas
ECONOMIA2 días agoA cuánto llegará el dólar en abril de 2026, según los principales analistas de mercado












